Who to call at Telomir Pharmaceuticals Inc., and when
Fundz watches for the moments Telomir Pharmaceuticals Inc. starts buying, and tells you who to reach.
- An alert the day Telomir Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Telomir Pharmaceuticals Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Telomir Pharmaceuticals Inc.. With Fundz connected, it knows.
Telomir Pharmaceuticals Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
telomirpharma.comAI Executive Summary
AI-powered analysis of 8-K filing content
Craig Eagle resigned from the Board of Directors of Telomir Pharmaceuticals Inc. effective immediately on November 14, 2025, and the filing states the resignation was not due to any disagreement with the company, management, or the board. The change affects board composition but the filing discloses no financial impact.
Key Takeaways
Director Craig Eagle resigned from the Board effective immediately on November 14, 2025, and the 8-K was filed November 20, 2025.
The filing states the resignation was not the result of any disagreement with the company, its management, or any other board member, which lowers the likelihood of an undisclosed governance dispute.
2 more takeaways
Related Filings (23)
23 more filings from Telomir Pharmaceuticals Inc. in the last 90 days
Filing Overview
What This Means
Telomir Pharmaceuticals Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.